Clinical Trials Browser

Prostate Adenocarcinoma × apalutamide × Genitourinary × Clear all

NCT02721979 2023-02-09

Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance

Phase 2 Terminated

24 enrolled 16 charts

Prostate Adenocarcinoma